These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1039 related items for PubMed ID: 12137559

  • 21. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD.
    Drug Saf; 2010 Mar 01; 33(3):171-87. PubMed ID: 20158283
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative tolerability of the HMG-CoA reductase inhibitors.
    Farmer JA, Torre-Amione G.
    Drug Saf; 2000 Sep 01; 23(3):197-213. PubMed ID: 11005703
    [Abstract] [Full Text] [Related]

  • 26. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May 01; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 27. Does simvastatin cause more myotoxicity compared with other statins?
    Backes JM, Howard PA, Ruisinger JF, Moriarty PM.
    Ann Pharmacother; 2009 Dec 01; 43(12):2012-20. PubMed ID: 19920157
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Myotoxicity and rhabdomyolisis due to statins].
    Banga JD.
    Ned Tijdschr Geneeskd; 2001 Dec 08; 145(49):2371-6. PubMed ID: 11770264
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Myotoxicity associated with lipid-lowering drugs.
    Baer AN, Wortmann RL.
    Curr Opin Rheumatol; 2007 Jan 08; 19(1):67-73. PubMed ID: 17143099
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Statin myopathy.
    Radcliffe KA, Campbell WW.
    Curr Neurol Neurosci Rep; 2008 Jan 08; 8(1):66-72. PubMed ID: 18367041
    [Abstract] [Full Text] [Related]

  • 36. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH, Zakowski LJ, McBride PE.
    WMJ; 2002 Jan 08; 101(7):53-6. PubMed ID: 12426921
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Statin induced myotoxicity.
    Sathasivam S.
    Eur J Intern Med; 2012 Jun 08; 23(4):317-24. PubMed ID: 22560377
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.